HoloLens 1 vs. HoloLens 2: Improvements in the New Model for Orthopedic Oncological Interventions.

3D printing Microsoft HoloLens 1 Microsoft HoloLens 2 augmented reality computer-assisted interventions orthopedic oncology

Journal

Sensors (Basel, Switzerland)
ISSN: 1424-8220
Titre abrégé: Sensors (Basel)
Pays: Switzerland
ID NLM: 101204366

Informations de publication

Date de publication:
29 Jun 2022
Historique:
received: 27 04 2022
revised: 20 06 2022
accepted: 27 06 2022
entrez: 9 7 2022
pubmed: 10 7 2022
medline: 14 7 2022
Statut: epublish

Résumé

This work analyzed the use of Microsoft HoloLens 2 in orthopedic oncological surgeries and compares it to its predecessor (Microsoft HoloLens 1). Specifically, we developed two equivalent applications, one for each device, and evaluated the augmented reality (AR) projection accuracy in an experimental scenario using phantoms based on two patients. We achieved automatic registration between virtual and real worlds using patient-specific surgical guides on each phantom. They contained a small adaptor for a 3D-printed AR marker, the characteristic patterns of which were easily recognized using both Microsoft HoloLens devices. The newest model improved the AR projection accuracy by almost 25%, and both of them yielded an RMSE below 3 mm. After ascertaining the enhancement of the second model in this aspect, we went a step further with Microsoft HoloLens 2 and tested it during the surgical intervention of one of the patients. During this experience, we collected the surgeons' feedback in terms of comfortability, usability, and ergonomics. Our goal was to estimate whether the improved technical features of the newest model facilitate its implementation in actual surgical scenarios. All of the results point to Microsoft HoloLens 2 being better in all the aspects affecting surgical interventions and support its use in future experiences.

Identifiants

pubmed: 35808407
pii: s22134915
doi: 10.3390/s22134915
pmc: PMC9269857
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI18/01625
Organisme : Instituto de Salud Carlos III
ID : AC20/00102-3
Organisme : Asociación Española Contra el Cáncer
ID : PerPlanRT
Organisme : Comunidad de Madrid
ID : IND2018/TIC-9753

Références

Eur Radiol Exp. 2018;2(1):2
pubmed: 29708204
Healthc Technol Lett. 2017 Sep 14;4(5):184-187
pubmed: 29184662
Int J Med Robot. 2018 Aug;14(4):e1914
pubmed: 29708640
Acta Neurochir (Wien). 2019 Oct;161(10):2181-2193
pubmed: 31300886
Sensors (Basel). 2021 Feb 15;21(4):
pubmed: 33672053
BMC Musculoskelet Disord. 2020 Feb 15;21(1):103
pubmed: 32061248
J Oral Implantol. 1989;15(1):41-6
pubmed: 2561372
Medicine (Baltimore). 2017 Sep;96(37):e8083
pubmed: 28906410
Healthc Technol Lett. 2018 Oct 4;5(5):221-225
pubmed: 30464854
N Am Spine Soc J. 2021 May 01;6:100065
pubmed: 35141630
Radiology. 2019 Jun;291(3):570-580
pubmed: 30990383
Int J Med Educ. 2020 Jan 18;11:1-18
pubmed: 31955150
IEEE Trans Med Imaging. 1998 Oct;17(5):694-702
pubmed: 9874293
Sensors (Basel). 2020 Feb 14;20(4):
pubmed: 32074980
Int J Med Robot. 2019 Apr;15(2):e1969
pubmed: 30447128
J Healthc Eng. 2017;2017:4574172
pubmed: 29065604
J Vis Exp. 2020 Jan 2;(155):
pubmed: 31957749
Healthc Technol Lett. 2018 Sep 14;5(5):162-166
pubmed: 30464847
Sensors (Basel). 2021 Nov 24;21(23):
pubmed: 34883825
Int J Med Robot. 2009 Dec;5(4):423-34
pubmed: 19621334
Eur Radiol. 2021 Dec;31(12):8897-8902
pubmed: 34109488
Int J Oral Maxillofac Surg. 2005 May;34(3):247-51
pubmed: 15741031
Eur Radiol Exp. 2018 Jul 31;2:18
pubmed: 30148251
J Clin Med. 2020 May 17;9(5):
pubmed: 32429549
Surg Innov. 2019 Feb;26(1):86-94
pubmed: 30261829
PLoS One. 2016 Jan 12;11(1):e0146996
pubmed: 26757365

Auteurs

Alicia Pose-Díez-de-la-Lastra (A)

Departamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid, 28911 Leganés, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, 28007 Madrid, Spain.

Rafael Moreta-Martinez (R)

Departamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid, 28911 Leganés, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, 28007 Madrid, Spain.

Mónica García-Sevilla (M)

Departamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid, 28911 Leganés, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, 28007 Madrid, Spain.

David García-Mato (D)

Departamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid, 28911 Leganés, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, 28007 Madrid, Spain.

José Antonio Calvo-Haro (JA)

Instituto de Investigación Sanitaria Gregorio Marañón, 28007 Madrid, Spain.
Servicio de Cirugía Ortopédica y Traumatología, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Departamento de Cirugía, Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.

Lydia Mediavilla-Santos (L)

Instituto de Investigación Sanitaria Gregorio Marañón, 28007 Madrid, Spain.
Servicio de Cirugía Ortopédica y Traumatología, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Departamento de Cirugía, Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.

Rubén Pérez-Mañanes (R)

Instituto de Investigación Sanitaria Gregorio Marañón, 28007 Madrid, Spain.
Servicio de Cirugía Ortopédica y Traumatología, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Departamento de Cirugía, Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.

Felix von Haxthausen (F)

Institute for Robotics and Cognitive Systems, University of Lübeck, 23562 Lübeck, Germany.

Javier Pascau (J)

Departamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid, 28911 Leganés, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, 28007 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH